You are here

rhinosinusitis

GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population

GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population

Endpoints

clinical trials

Flag link:

Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polyps

Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polyps

Fierce Pharma

Flag link:

Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII

Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII

Endpoints

Flag link: